FibroGen

Tim C. Opler has been named vice president of strategy at FibroGen. He will focus on matters involving strategic planning, organizational development, and financial markets.

Mr. Opler brings 15 years of experience in financial services and academia. He was most recently managing director at Credit Suisse in healthcare investment banking where he was responsible for a series of financial and strategic transactions in the biotechnology and pharmaceutical areas. Mr. Opler began his Wall Street career in 1997 as a director at Deutsche Bank. Earlier, he was a finance professor at Southern Methodist University and The Ohio State University. He began his career as a research analyst at the Rand Corporation and held several teaching positions at University of California, Los Angeles.

“Tim will play a key role in strategic planning and organizational development in preparation for the growth and maturation of our product portfolio,” said Thomas B. Neff, Chief Executive Officer of FibroGen. “I look forward to Tim’s contributions and initiatives to help us develop a strong, vertically-integrated biopharmaceutical organization.”